Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

J. Biol. Chem. 280 (22): 20968-20977

© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.

Phosphoinositide 3-Kinase Accelerates Postoperative Tumor Growth by Inhibiting Apoptosis and Enhancing Resistance to Chemotherapy-induced Apoptosis

NOVEL ROLE FOR AN OLD ENEMY*

{boxs}

J. Calvin Coffey{ddagger}§, Jiang Huai Wang{ddagger}, Myles J. F. Smith{ddagger}, Alan Laing{ddagger}, David Bouchier-Hayes¶, Tom G. Cotter||**, , and H. Paul Redmond{ddagger}

Departments of {ddagger}Surgery, ||Tumor Biology, and **Biochemistry, Cork University Hospital, Wilton, Cork, Munster, Ireland and the Department Surgery, Beaumont Hospital and Royal College of Surgeons, Dublin, Ireland

Abstract: Tumor removal remains the principal treatment modality in the management of solid tumors. The process of tumor removal may potentiate the resurgent growth of residual neoplastic tissue. Herein, we describe a novel murine model in which flank tumor cytoreduction is followed by accelerated local tumor recurrence. This model held for primary and recurrent tumors generated using a panel of human and murine (LS174T, DU145, SW480, SW640, and 3LL) cell lines and replicated accelerated tumor growth following excisional surgery. In investigating this further, epithelial cells were purified from LS174T primary and corresponding recurrent tumors for comparison. Baseline as well as tumor necrosis factor apoptosis-inducing ligand (TRAIL)-induced apoptosis were significantly reduced in recurrent tumor epithelia. Primary and recurrent tumor gene expression profiles were then compared. This identified an increase and reduction in the expression of p110{gamma} and p85{alpha} class Ia phosphoinositide 3-kinase (PI3K) subunits in recurrent tumor epithelia. These changes were further confirmed at the protein level. The targeting of PI3K ex vivo, using LY294002, restored sensitivity to TRAIL in recurrent tumor epithelia. In vivo, adjuvant LY294002 prolonged survival and significantly attenuated recurrent tumor growth by greatly enhancing apoptosis levels. Hence, PI3K plays a role in generating the antiapoptotic and chemoresistant phenotype associated with accelerated local tumor recurrence.


Received for publication December 30, 2004. Revision received February 15, 2005.

* This work was supported by research grants from the Health Research Board Ireland and also from Aid Cancer Treatment. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


{boxs}

The on-line version of this article (available at http://www.jbc.org) contains additional text.

§ To whom correspondence should be addressed: Tel.: 35-386-838-2421; Fax: 35-321-492-2811; E-mail: calvincoffey{at}hotmail.com.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
BAY 80-6946 Is a Highly Selective Intravenous PI3K Inhibitor with Potent p110{alpha} and p110{delta} Activities in Tumor Cell Lines and Xenograft Models.
N. Liu, B. R. Rowley, C. O. Bull, C. Schneider, A. Haegebarth, C. A. Schatz, P. R. Fracasso, D. P. Wilkie, M. Hentemann, S. M. Wilhelm, et al. (2013)
Mol. Cancer Ther. 12, 2319-2330
   Abstract »    Full Text »    PDF »
Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy.
G. Grisendi, R. Bussolari, L. Cafarelli, I. Petak, V. Rasini, E. Veronesi, G. De Santis, C. Spano, M. Tagliazzucchi, H. Barti-Juhasz, et al. (2010)
Cancer Res. 70, 3718-3729
   Abstract »    Full Text »    PDF »
Tolerization with BLP down-regulates HMGB1 a critical mediator of sepsis-related lethality.
J. C. Coffey, J. H. Wang, R. Kelly, L. Romics Jr., A. O'Callaghan, C. Fiuza, and H. P. Redmond (2007)
J. Leukoc. Biol. 82, 906-914
   Abstract »    Full Text »    PDF »
Mapping Genes that Contribute to Daunorubicin-Induced Cytotoxicity.
S. Duan, W. K. Bleibel, R. S. Huang, S. J. Shukla, X. Wu, J. A. Badner, and M. E. Dolan (2007)
Cancer Res. 67, 5425-5433
   Abstract »    Full Text »    PDF »
FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway.
V. Thamilselvan, D. H. Craig, and M. D. Basson (2007)
FASEB J 21, 1730-1741
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882